Back to top

Why Is CytomX (CTMX) Stock Down 43% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CytomX Therapeutics stock is falling hard on Thursday after the company posted lackluster results in a cancer treatment clinical trial update.

The post Why Is CytomX (CTMX) Stock Down 43% Today? appeared first on InvestorPlace.

More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AMC Entertainment Holdings, Inc. (AMC)

CytomX Therapeutics, Inc. (CTMX)

HubSpot, Inc. (HUBS)

Roblox Corporation (RBLX)